St. Luke's University Health Network

Easton, Pennsylvania 18045

Use our guide to learn which trials are right for you!

We've found
5 trials
at this facility
Renal Cell Carcinoma Clinical Trial
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Easton, PA
Click here to add this to my saved trials
Solid Tumors Clinical Trial
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Easton, PA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Easton, PA
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Phase I of UV1 Vaccine With Pembrolizumab
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Easton, PA
Click here to add this to my saved trials
Head and Neck Neoplasms Clinical Trial
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Easton, PA
Click here to add this to my saved trials